Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG2 | P78540 | 12/20 | 0.63 |
| ▸ | ARG1 | P05089 | 11/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | ODC1 | P11926 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6666220 | 1.00 | ARG2 (0.63) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL8842963 | 0.93 | ARG2 (0.67) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL23829640 | 0.91 | ARG1 (0.65) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL11629171 | 0.91 | ARG1 (0.65) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL30549568 | 0.91 | ARG1 (0.65) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL9273320 | 0.91 | ARG1 (0.65) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL185635 | 0.91 | ARG1 (0.52) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL8203128 | 0.90 | ARG1 (0.62) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL6129347 | 0.86 | ARG2 (0.53) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL23010905 | 0.86 | ARG1 (0.48) | ARG2ARG1MEN1ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0775126-B1 | HYPOLIPIDEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES | WELLCOME FOUND (GB) | 2002-10-30 | — | — | EP | disclosed |
| EP-1203769-A1 | Hypolipidemic 1,4-benzothiazepine derivative | THE WELLCOME FOUNDATION LIMITED (GB) | 2002-05-08 | — | — | EP | disclosed |
| CN-1059673-C | Hypolipidemic 1, 4-benzazepine * -1, 1-dioxides | WELLCOME FOUND (GB) | 2000-12-20 | — | — | CN | disclosed |
| US-5910494-A | NOVEL COMPOUNDS THAT REDUCE THE ABSORPTION OF BILE ACIDS FROM THE INTESTINE; FOR PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC CONDITIONS, SUCH AS ATHEROSCLEROSIS | GLAXO WELLCOME INC. (US) | 1999-06-08 | — | — | US | disclosed |
| EP-0626952-B1 | HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDS | WELLCOME FOUND (GB) | 1999-04-14 | — | — | EP | disclosed |
| US-5859240-A | REDUCTION OF IMINE GROUP; OXIDATION; SALT FORMATION | GLAXO WELLCOME INC. (US) | 1999-01-12 | — | — | US | disclosed |
| CN-1161035-A | Hypolipidemic 1,4-benzothiazepine-1,1-dioxides | WELLCOME FOUND (GB) | 1997-10-01 | — | — | CN | disclosed |
| US-5663165-A | ANTICHOLESTEROL, CARDIOVASCULAR | GLAXO WELLCOME INC. (US) | 1997-09-02 | — | — | US | disclosed |
| EP-0626952-A1 | HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993016055-A1 | HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-08-19 | — | — | WO | disclosed |